Filing Flows

Filing Flows › Medline (MDLN) › Next earnings date

Medline (MDLN) earnings: beat the estimate

Medline (MDLN) reported on Nov 4, 2026 and beat the EPS estimate: $0.44 against $0.35 (+26.1%). Revenue was $7.9B for Q3 2026, +10% year over year. It beat the EPS estimate in 100% of the quarters on record.

Last result+26.1% vs estimate
Beat rate100%

The last report

Medline reported revenue of $7.9B for the third quarter 2026 (+10% Y/Y), net earnings $198M. How it makes money → · Every quarter →

Medline: EPS against the estimate, last 4 reportsMedline: EPS against the estimate, last 4 reportsEstimateReported$0.24$0.31Feb 26$0.29$0.33May 26$0.32$0.50Aug 26$0.35$0.44Nov 26
Latest (Nov 26): Estimate $0.35, Reported $0.44.

Medline's latest quarter

Medline, Q3 2026: revenue $7.9B (+10% year over year), operating margin 6.4%, net earnings $198M, operating cash flow $1.0B. The chart follows the revenue to costs, profit and cash.

Questions

Did Medline beat earnings?

Medline (MDLN) reported on Nov 4, 2026 and beat the EPS estimate: $0.44 against $0.35 (+26.1%).

When does MDLN report earnings?

The next date is not set yet.

Does Medline usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.